Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacand and HCT in Hypertensive Adults
NCT00434967Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2007
- Primary completion
- Jan 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of candesartan in hypertension (HTN), sponsored by AstraZeneca. Started Jan 2007; status: completed.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00434967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434967.